Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 301–400 of 999
Abdollah, F., Sun, M., Schmitges, J., Thuret, R., Bianchi, M., Shariat, S. F., Briganti, A., Claudio Jeldres, A., Perrotte, P., Montorsi, F., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.03.005 · Cited by 46
Daskivich, T. J., Kwan, L. C., Dash, A., Saigal, C. S., & Litwin, M. S. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.01.081 · Cited by 42
Li, S.-L., Ye, Y., & Yuan, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171081 · Cited by 44
Sinnott, M., Falzarano, S. M., Hernández, A. V., Jones, J. S., Klein, E. A., Zhou, M., & Magi‐Galluzzi, C. (2011) · The Prostate · doi:10.1002/pros.22467 · Cited by 42
Tumour Features in the Control and Screening Arm of A Randomized Trial of Prostate Cancer
Postma, R., van Leenders, A. G. J. L. H., Roobol, M. J., Schröder, F. H., & van der Kwast, T. (2005) · European Urology · doi:10.1016/j.eururo.2005.11.005 · Cited by 41
Lu‐Yao, G. L., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0785-8 · Cited by 40
Karademir, İ., Shen, D. G., Peng, Y., Liao, S., Jiang, Y., Yousuf, A. N., Karczmar, G. S., Sammet, S., Wang, S., Medved, M., et al. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.13.10591 · Cited by 40
Perspectives on making big data analytics work for oncology
Naqa, I. E. (2016) · Methods · doi:10.1016/j.ymeth.2016.08.010 · Cited by 47
Viewpoint: Limiting Prostate Cancer Screening
Hoffman, R. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00011 · Cited by 40
Judge, A., Evans, S., Gunnell, D., Albertsen, P. C., Verne, J., & Martin, R. M. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07118.x · Cited by 41
Dandapani, S. V., & Sanda, M. G. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.10.001 · Cited by 39
Clinical significance of the positive surgical margin based upon location, grade, and stage
Fleshner, N. E., Evans, A. J., Chadwick, K., Lawrentschuk, N., & Zlotta, A. R. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.08.015 · Cited by 39
Prostate cancer and prostate‐specific antigen testing in New South Wales
Smith, D. P., Supramaniam, R., Marshall, V. R., & Armstrong, B. K. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02048.x · Cited by 39
Low Life Expectancy in the United States: Is the Health Care System at Fault?
Preston, S. H., & Ho, J. Y. (2009) · National Bureau of Economic Research · doi:10.3386/w15213 · Cited by 59
Feletto, E., Bang, A., Cole‐Clark, D., Chalasani, V., Rasiah, K., & Smith, D. P. (2015) · World Journal of Urology · doi:10.1007/s00345-015-1514-7 · Cited by 38
Xiong, T., Turner, R., Wei, Y., Neal, D. E., Lyratzopoulos, G., & Higgins, J. P. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004285 · Cited by 41
Kawamura, K., Suzuki, H., Kamiya, N., Imamoto, T., Yano, M., Miura, J., Shimbo, M., Suzuki, N., Nakatsu, H., & Ichikawa, T. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02058.x · Cited by 38
Makarov, D. V., Loeb, S., Landman, A., Nielsen, M. E., Gross, C. P., LESLIE, D. L., Penson, D. F., & Desai, R. A. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.12.014 · Cited by 38
Wang, Y., Wang, C., Fang, F., Chen, H., Hsu, H., Huang, Y.-J., Wang, C., & Huang, E. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.034 · Cited by 38
Nelson, C. J., Lacey, S., Kenowitz, J., Pessin, H., Shuk, E., Roth, A. J., & Mulhall, J. P. (2015) · Psycho-Oncology · doi:10.1002/pon.3771 · Cited by 37
Prostate Cancer: Epidemiology and Health-related Quality of Life
Penson, D. F., Rossignol, M., Sartor, O. A., Scardino, P. T., & Abenhaim, L. L. (2008) · Urology · doi:10.1016/j.urology.2008.10.006 · Cited by 38
Wallis, C. J. D., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Chang, M., Kulkarni, G. S., Lee, Y., Kodama, R. T., Narod, S. A., et al. (2015) · Urology · doi:10.1016/j.urology.2014.11.037 · Cited by 39
Ghodraty-Jabloo, V., Alibhai, S. M. H., Fitch, M. I., Tourangeau, A. E., Ayala, A. P., & Puts, M. T. E. (2017) · Oncology nursing forum · doi:10.1188/17.onf.e152-e167 · Cited by 46
Holmes, L., Chan, W., Jiang, Z., & Du, X. L. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500973 · Cited by 38
Progression after radical prostatectomy for men in their thirties compared to older men
Loeb, S., Hernandez, D. J., Mangold, L. A., Humphreys, E. B., Agro, M., Walsh, P. C., Partin, A. W., & Han, M. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07500.x · Cited by 37
Pettersson, A., Johansson, B., Persson, C., Berglund, A., & Turesson, I. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.04.006 · Cited by 41
Rethinking prostate cancer screening: could MRI be an alternative screening test?
Eldred‐Evans, D., Tam, H., Sokhi, H. K., Padhani, A. R., Winkler, M. H., & Ahmed, H. U. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0356-2 · Cited by 42
Sengupta, S., Blute, M. L., Bagniewski, S. M., Inman, B. A., Leibovich, B. C., Slezak, J. M., Myers, R. P., & Zincke, H. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07270.x · Cited by 36
Malaeb, B. S., Rashid, H. H., Lotan, Y., Khoddami, S. M., Shariat, S. F., Sagalowsky, A. I., McConnell, J. D., Roehrborn, C. G., & Koeneman, K. S. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.08.001 · Cited by 36
Liu, L., Coker, A. L., Du, X. L., Cormier, J. N., Ford, C. E., & Fang, S. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21028 · Cited by 37
Yu, X. Q., O’Connell, D. L., Gibberd, R. W., Coates, A. S., & Armstrong, B. K. (2006) · International Journal of Cancer · doi:10.1002/ijc.21909 · Cited by 36
Bhatnagar, V., Stewart, S. T., Huynh, V., Jørgensen, G. M., & Kaplan, R. M. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500855 · Cited by 36
Nelson, C. J., & Kenowitz, J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12049 · Cited by 37
Pelzer, A. E., Bektić, J., Akkad, T., Ongarello, S., Schaefer, G., Schwentner, C., Frauscher, F., Bartsch, G. C., & Horninger, W. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.021 · Cited by 35
Radical prostatectomy for octogenarians: How old is too old?
Thompson, R. H., Slezak, J. M., Webster, W. S., & Lieber, M. M. (2006) · Urology · doi:10.1016/j.urology.2006.05.031 · Cited by 34
Epidemiology of prostate cancer and treatment remarks
Arcangeli, S. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i6.241 · Cited by 35
Gao, X., Li, L.-Y., Zhou, F.-J., Xie, K.-J., Shao, C., Su, Z.-L., Sun, Q.-P., Chen, M., Pang, J., Zhou, X.-F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2449 · Cited by 34
Active surveillance for favorable-risk prostate cancer: who, how and why?
Klotz, L. H. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0966 · Cited by 34
Rocco, B. M. C., Lorusso, A., Coelho, R. F., Palmer, K. J., & Patel, V. (2009) · Scandinavian Journal of Surgery · doi:10.1177/145749690909800202 · Cited by 34
Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial
Skolarus, T. A., Metreger, T., Wittmann, D. A., Hwang, S., Kim, H. M., Grubb, R. L., Gingrich, J. R., Zhu, H., Piette, J. D., & Hawley, S. T. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01770 · Cited by 35
What is low-risk prostate cancer and what is its natural history?
O'Donnell, H., & Parker, C. C. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0277-9 · Cited by 34
Advances in the Treatment of Prostate Cancer
Pomerantz, M. M., & Kantoff, P. W. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.101505.115650 · Cited by 34
Gulcher, J. R., & Stefánsson, K. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02233.x · Cited by 34
Sexual Dysfunction Following Radical Prostatectomy
Benson, C. R., Şerefoğlu, E. C., & Hellstrom, W. J. G. (2012) · Journal of Andrology · doi:10.2164/jandrol.112.016790 · Cited by 35
Patients' Survival Expectations before Localized Prostate Cancer Treatment by Treatment Status
Mohan, R., Beydoun, H. A., Barnes-Ely, M. L., Lee, L., Davis, J. W., Lance, R., & Schellhammer, P. F. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.03.080200 · Cited by 32
Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer
Chamie, K., Daskivich, T. J., Kwan, L. C., Labo, J., Dash, A., Greenfield, S., & Litwin, M. S. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1869-4 · Cited by 33
Jayadevappa, R., Chhatre, S., Whittington, R., Bloom, B. S., Wein, A. J., & Malkowicz, S. B. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06128.x · Cited by 33
Porter, C. R., Andrea Gallina, A., Kodama, K., Gibbons, R. P., Correa, R. J., Perrotte, P., & Karakiewicz, P. I. (2006) · European Urology · doi:10.1016/j.eururo.2006.11.027 · Cited by 33
Heidenreich, A., Joaquim Bellmunt, B., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H., van der Kwast, T., Wiegel, T., et al. (2011) · Actas Urológicas Españolas · doi:10.4321/s0210-48062011000900001 · Cited by 32
Kwon, T., Jeong, I. G., You, D., Park, M., Hong, J. H., Ahn, H., & Kim, C. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09182.x · Cited by 32
Hammarsten, P., Cipriano, M., Josefsson, A., Stattin, P. E., Egevad, L., Granfors, T., & Fowler, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047994 · Cited by 34
Xylinas, E. N., Ploussard, G., Durand, X., TAILLE, A. D. L., Gillion, N., Allory, Y., Vordos, D., Hoznek, A., Abbou, C.-C., & Salomon, L. (2010) · Urology · doi:10.1016/j.urology.2010.03.096 · Cited by 32
Conceptual Basis for Focal Therapy in Prostate Cancer
Lecornet, E., Ahmed, H. U., Moore, C. M., & Emberton, M. (2010) · Journal of Endourology · doi:10.1089/end.2009.0654 · Cited by 32
Gasińska, A., Jaszczyński, J., Rychlik, U., Łuczyńska, E., Pogodziński, M., & Mikolaj, P. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00659-4 · Cited by 32
Fransson, P., Damber, J., & Widmark, A. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590802519396 · Cited by 32
Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?
Patel, A. R., & Stephenson, A. J. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.80 · Cited by 34
Techniques of nerve-sparing and potency outcomes following robot-assisted laparoscopic prostatectomy
Chauhan, S., Coelho, R. F., Rocco, B. M. C., Palmer, K. J., Orvieto, M. A., & Patel, V. (2010) · International braz j urol · doi:10.1590/s1677-55382010000300002 · Cited by 32
Khatami, A., Hugosson, J., Wang, W., & Damber, J. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590802469543 · Cited by 32
Adolfsson, J., Tribukait, B., & Levitt, S. H. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.002 · Cited by 32
The potential impact of comparative effectiveness research on U.S. Health Care expenditures
Perlroth, D. J., Goldman, D. P., & Garber, A. M. (2010) · Demography · doi:10.1353/dem.2010.0004 · Cited by 31
An explicit values clarification task: Development and validation
Feldman‐Stewart, D., Brennenstuhl, S., Brundage, M., & Roques, T. W. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.04.001 · Cited by 31
Barqawi, A. B., & Crawford, E. D. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318156eb99 · Cited by 31
Radiotherapy and Survival in Prostate Cancer Patients: A Population-Based Study
Zhou, E. H., Ellis, R. J., Cherullo, E. E., Colussi, V., Xu, F., Chen, W.-D. D., Gupta, S., Whalen, C. C., Bodner, D. R., Resnick, M. I., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.001 · Cited by 31
Kaye, D. R., Qi, J., Morgan, T. M., Linsell, S. M., Ginsburg, K., Lane, B. R., Montie, J. E., Cher, M. L., Miller, D. C., & Collaborative, T. M. U. S. I. (2018) · British Journal of Urology · doi:10.1111/bju.14554 · Cited by 31
Heidenreich, A., Joaquim Bellmunt, B., Bolla, M., Joniau, S., Mason, M. D., Matveev, V. B., Mottet, N., Schmid, H., van der Kwast, T., Wiegel, T., et al. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2011.12.003 · Cited by 31
Klotz, L. H. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0993 · Cited by 31
Porter, M. P., Stanford, J. L., & Lange, P. H. (2006) · The Prostate · doi:10.1002/pros.20417 · Cited by 36
Prognostic Markers Under Watchful Waiting and Radical Prostatectomy
Holmberg, L., Bill‐Axelson, A., Garmo, H., Palmgren, J., Norlén, B. J., Adami, H., & Johansson, J. E. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.007 · Cited by 31
Self-citationActive Surveillance for Favorable Risk Prostate Cancer: What Are the Results, and How Safe Is It?
Klotz, L. H. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.09.001 · Cited by 30
Innovations in prostate biopsy strategies for active surveillance and focal therapy
Ukimura, O., Hung, A. J., & Gill, I. S. (2010) · Current Opinion in Urology · doi:10.1097/mou.0b013e3283435118 · Cited by 30
Fairley, L., Baker, M., Whiteway, J. A., Cross, W. R., & Forman, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605424 · Cited by 30
Hoffman, K. E., Chen, M., Moran, B. J., Braccioforte, M. H., Dosoretz, D. E., Salenius, S. A., Katin, M. J., Ross, R., & D'Amico, A. V. (2010) · Cancer · doi:10.1002/cncr.24974 · Cited by 30
Bone imaging in prostate cancer
Dotan, Z. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1190 · Cited by 30
Watchful waiting for prostate cancer: a review article
Chodak, G. W., & Warren, K. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500857 · Cited by 30
Ramsey, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9805 · Cited by 30
Active surveillance for favorable risk prostate cancer: Rationale, risks, and results
Klotz, L. H. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.021 · Cited by 30
SPCG-4: A Needed START to PIVOTal Data to Promote and ProtecT Evidence-Based Prostate Cancer Care
Wilt, T. J. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn259 · Cited by 30
Rouanne, M., Vaessen, C., Bitker, M., Chartier-Kastler, E. J., & Morgan Rouprêt, A. (2011) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31821c4931 · Cited by 29
Focal therapy in the management of localized prostate cancer
Nguyen, C. T., & Jones, J. S. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09975.x · Cited by 29
Giovanni Lughezzani, A., Andrea Gallina, A., Larcher, A., Briganti, A., Umberto Capitanio, A., Suardi, N. R., Lista, G., Abrate, A., Sangalli, M. N., Buffi, N. M., et al. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11114.x · Cited by 29
PSA screening: determinants of primary-care physician practice patterns
Tasian, G. E., Cooperberg, M. R., Potter, M. B., Cowan, J. E., Greene, K. L., Carroll, P. R., & Chan, J. M. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.59 · Cited by 32
Current decision-making in prostate cancer therapy
Cox, J., & Amling, C. L. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3282fba5f2 · Cited by 29
Yasunaga, H., Ide, H., Imamura, T., & Ohe, K. (2006) · Urology · doi:10.1016/j.urology.2006.06.009 · Cited by 29
Is Radical Prostatectomy the “Gold Standard” for Localized Prostate Cancer?
Mendenhall, W. M., Nichols, R. C., Henderson, R. H., & Mendenhall, N. P. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181b4af05 · Cited by 31
Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study
Lawrentschuk, N., Evans, A. J., Srigley, J. R., Chin, J. L., Bora, B., Hunter, A., McLeod, R. S., & Fleshner, N. E. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.10085 · Cited by 27
Lao, C., Edlin, R. P., Rouse, P., Brown, C., Holmes, M., Gilling, P. J., & Lawrenson, R. A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3522-z · Cited by 28
Spinal Cord Stimulation for Testicular Pain
Nouri, K. H., & Brish, E. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01210.x · Cited by 27
Watchful Waiting and Quality of Life Among Prostate Cancer Survivors in the Physicians' Health Study
Kasperzyk, J. L., Shappley, W. V., Kenfield, S. A., Mucci, L. A., Kurth, T., Ma, J., Stampfer, M. J., & Sanda, M. G. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.06.058 · Cited by 31
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men
Shao, Y.-H., Albertsen, P. C., Shih, W. J., Roberts, C. B., & Lu‐Yao, G. L. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.29 · Cited by 27
Sajid, S., Mohile, S. G., Szmulewitz, R. Z., Posadas, E. M., & Dale, W. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.011 · Cited by 29
Hegarty, J. M., Wallace, M. E., & Comber, H. (2007) · American Journal of Men s Health · doi:10.1177/1557988307300467 · Cited by 27
Population-Based Case-Control Study of PSA and DRE Screening on Prostate Cancer Mortality
Bergstralh, E. J., Roberts, R. O., Farmer, S. A., Slezak, J. M., Lieber, M. M., & Jacobsen, S. J. (2007) · Urology · doi:10.1016/j.urology.2007.07.009 · Cited by 27
Sonablate®-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer
Illing, R. O., & Emberton, M. (2006) · Expert Review of Medical Devices · doi:10.1586/17434440.3.6.717 · Cited by 27
Metabolic syndrome and prostate cancer
Glodé, L. M. (2008) · Cancer · doi:10.1002/cncr.23511 · Cited by 29
ProCOC: The prostate cancer outcomes cohort study
Umbehr, M., Kessler, T. M., Sulser, T., Kristiansen, G., Probst, N., Steurer, J., & Bachmann, L. M. (2008) · BMC Urology · doi:10.1186/1471-2490-8-9 · Cited by 25
Chung, S., Kelle, J. J., Huang, C., Chen, Y., & Lin, H. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11183.x · Cited by 26
Lindner, U., Lawrentschuk, N., Weersink, R., Raz, O. E., Hlasny, E., Sussman, M. S., Davidson, S. R., Gertner, M. R., & Trachtenberg, J. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.03.001 · Cited by 26
Low risk prostate cancer in men under age 65: The case for definitive treatment
Jang, T. L., Yossepowitch, O., Bianco, F. J., & Scardino, P. T. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.025 · Cited by 26
TRANSITION FROM OPEN TO ROBOTIC‐ASSISTED RADICAL PROSTATECTOMY
Prokar Dasgupta, A., Patil, K., Anderson, C. J., & Kirby, R. S. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07440.x · Cited by 26
Clinically localised prostate cancer
Wilt, T. J., & Thompson, I. M. (2006) · BMJ · doi:10.1136/bmj.39022.423588.de · Cited by 27
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.